round button
Leave a message

Global Auto Injectors Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Global Auto Injectors Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Oct 2024
  • Global
  • 350 Pages
  • Количество таблиц: 60
  • Количество рисунков: 220

Global Auto Injectors Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Chart Image USD 83.05 Billion USD 401.48 Billion 2023 2031
Diagram Прогнозируемый период
2024 –2031
Diagram Размер рынка (базовый год)
USD 83.05 Billion
Diagram Размер рынка (прогнозируемый год)
USD 401.48 Billion
Diagram CAGR
%
Diagram Основные игроки рынка
  • AbbVie
  • Mylan N.V.
  • Lily
  • Amgen
  • Ypsomed Holding

>Global Auto Injectors Market Segmentation, By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies), Type (Disposable Auto injectors, Reusable Auto Injectors), End- User (Home Care Settings, Hospitals and Clinics, Ambulatory Surgical Centers), Route of administration (Subcutaneous, Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Design (Standardized, Customized), Product (Prefilled, Fillable) – Industry Trends and Forecast to 2031

Auto Injectors Market

Auto Injectors Market Analysis

Auto injectors are utilized for epinephrine self-administration in order to prevent anaphylaxis, for immediate pain relief by migraine sufferers and for medical and emergency treatments. The rise in incidence of anaphylaxis is escalating the growth of auto injectors market.

Auto Injectors Market Size

Global auto injectors market size was valued at USD 83.05 billion in 2023 and is projected to reach USD 401.48 billion by 2031, with a CAGR of 21.77% during the forecast period of 2024 to 2031.

Report Scope and Market Segmentation       

Attributes

Auto Injectors Key Market Insights

Segmentation

  • By Therapy: Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies
  • By Type: Disposable Auto injectors, Reusable Auto Injectors
  • By End- User: Home Care Settings, Hospitals and Clinics, Ambulatory Surgical Centers
  • By Route of administration: Subcutaneous, Intramuscular
  • By Type of Molecule: Monoclonal Antibody, Peptide, Protein, and Small Molecule
  • By Design: Standardized, Customized
  • By Product: Prefilled, Fillable

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Key Market Players

AbbVie Inc. (US), Mylan N.V. (US), Lily. (US), Amgen Inc. (US), Ypsomed Holding (Switzerland), BD (US), Owen Mumford Ltd. (UK), Consort Medical, Plc. (UK), SHL Medical AG (Switzerland), Johnson Medtech, LLC. (US), Teva Pharmaceuticals USA, Inc. (US), Antares Pharma. (New Jersey), AstraZeneca (UK), Union Medico Inc. (Denmark), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc (US), and Emergent. (US), among others

Auto Injectors Market Definition

An auto injector refers to a syringe with a spring-charged needle that has a pre-charged dosage of drugs. A measured dosage of a drug is triggered and administered when pressed into the body with a sliding motion. Auto-injectors offer various advantages such as, reducing needle-related phobia disorder, and risks of needle stuck accidents, among others.

Auto Injectors Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

  • Prevalence of Targeted Therapies

The increase in the prevalence of targeted therapies, such as alemtuzumab (certain chronic leukemias), and trastuzumab (certain breast cancers), among others acts as one of the major factors driving the growth of auto injectors market.

  • Funds and Grants

The surge in investments in the form of funds and grants for therapies associated with auto injectors accelerate the market growth.

  • Favorable reimbursements

The presence of favorable reimbursements and increasing government support further influence the auto injectors market.

Opportunities

Furthermore, patent expiry of biologics to drive the demand for biosimilars extend profitable opportunities to the market players in the forecast period of 2024 to 2031. Also, increasing the preference for self-administration will further expand the auto injectors market.

Restraints/Challenges Global Auto Injectors Market

On the other hand, increase in the preference for alternative drug delivery modes and development of nasal epinephrine sprays are expected to obstruct market growth. Also, development of autoinjectors for multiple drug viscosities and lack of proper training for using auto injectors are projected to challenge the auto injectors market in the forecast period of 2024-2031.

This auto injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on auto injectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Auto Injectors Market Scope

The auto injectors market is segmented on the basis of therapy, type, end- users, route of administration, molecule, design and product. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Therapy

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Diabetes
  • Anaphylaxis
  • Other Therapies

Type

  • Disposable Auto Injectors
  • Reusable Auto Injectors

End- Users

  • Home Care Settings
  • Hospitals and Clinics
  • Ambulatory Surgical Centers

Route of Administration

  • Subcutaneous
  • Intramuscular

Type of Molecule

  • Monoclonal Antibody
  • Peptide
  • Protein
  • Small Molecule

Design

  • Standardized
  • Customized

Product

  • Prefilled
  • Fillable

Auto Injectors Market Regional Analysis

The auto injector market is analysed and market size insights and trends are provided by country, therapy, type, end- users, route of administration, type of molecule, design and product as referenced above.

The countries covered in the auto injector market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the auto injector market because of the advancements in medical devices technologies and advanced healthcare infrastructure within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increasing incidence of diabetics and anaphylaxis due to food allergies in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The auto injector market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for auto injector market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the auto injector market. The data is available for historic period 2010-2020.

Auto Injectors Market Share

The auto injector market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to auto injector market.

Auto Injectors Market Leaders Operating in the Market Are:

  • AbbVie Inc. (US)
  • Mylan N.V. (US)
  • Lily. (US)
  • Amgen Inc. (US)
  • Ypsomed Holding (Switzerland)
  • BD (US)
  • Owen Mumford Ltd. (UK)
  • Consort Medical, Plc. (UK)
  • SHL Medical AG (Switzerland)
  • Johnson Medtech, LLC. (US)
  • Teva Pharmaceuticals USA, Inc. (US)
  • Antares Pharma. (New Jersey)
  • AstraZeneca (UK)
  • Union Medico Inc. (Denmark)
  • Gerresheimer AG (Germany)
  • West Pharmaceutical Services, Inc (US)
  • Emergent. (US)

Latest Developments in Auto Injectors Market

  • Antares Pharma (US) made an agreement with Lunatus Global Medical Supplies (Dubai) in August’2020. Antares is expected to supply packaged products to Lunatus according to the agreement. Lunatus will submit and obtain regulatory approval for XYOSTED in the UAE and Saudi Arabia, and will promote, market and distribute XYOSTED in these two countries

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

Рынок сегментирован на основе Segmentation, By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Other Therapies), Type (Disposable Auto injectors, Reusable Auto Injectors), End- User (Home Care Settings, Hospitals and Clinics, Ambulatory Surgical Centers), Route of administration (Subcutaneous, Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Design (Standardized, Customized), Product (Prefilled, Fillable) – Industry Trends and Forecast to 2031 .
Размер Global Auto Injectors Market в 2023 году оценивался в 83.05 USD Billion долларов США.
Ожидается, что Global Auto Injectors Market будет расти со среднегодовым темпом роста (CAGR) 21.77% в течение прогнозируемого периода 2024–2031.
Основные участники рынка включают AbbVie , Mylan N.V., Lily, Amgen , Ypsomed Holding, BD, Owen Mumford , Consort Medical Plc., SHL Medical AG, Johnson Medtech LLC., Teva Pharmaceuticals USA , Antares Pharma., AstraZeneca, Union Medico , Gerresheimer AG, West Pharmaceutical Services , Emergent-.
Отчет по рынку охватывает данные из U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Testimonial
a